Claire Mazumdar

BCAX

Claire Mazumdar serves as director, officer: Chief Executive Officer at Bicara Therapeutics Inc. Common Stock (BCAX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

4 trades

$1.85M

Net Position

Net Seller

$1.85M

Companies Traded

BCAX

Active Period

Oct 2025 – Mar 2026

4 total trades

Most Recent

Sell BCAX

Mar 6, 2026 · $154.3K

Claire Mazumdar's Insider Trading at Bicara Therapeutics Inc. Common Stock (BCAX)

Buys

0 · $0.00

Sells

4 · $1.85M

Total Shares Bought

Total Shares Sold

98,234

BCAX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Mar 6, 2026	Sell	8,234	$18.74	$154.3K	339,392
Nov 24, 2025	Sell	41,163	$18.86	$776.4K	0
Oct 16, 2025	Sell	24,103	$18.83	$453.8K	0
Oct 13, 2025	Sell	24,734	$18.88	$466.9K	0

Related Insiders

Ryan Cohlhepp

President and COO

BCAXSell · Mar 5, 2026

Ivan Hyep

officer: Chief Financial Officer

BCAXSell · Mar 5, 2026

David Raben

officer: Chief Medical Officer

BCAXSell · Mar 5, 2026

RA CAPITAL MANAGEMENT, L.P.

director, 10 percent owner:

BCAXBuy · Mar 2, 2026

Lara Meisner

Chief Legal Officer

BCAXSell · Sep 29, 2025

Explore More Insider Trading Data

BCAX Insider Trading Activity

View all insider trades at Bicara Therapeutics Inc. Common Stock

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity